These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33710158)

  • 21. Mastoid obliteration for pediatric suppurative cholesteatoma: long-term safety and sustained effectiveness after 30 years' experience with cartilage obliteration.
    Kuo CL; Lien CF; Shiao AS
    Audiol Neurootol; 2014; 19(6):358-69. PubMed ID: 25377728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration.
    Kroon VJ; Mes SW; Borggreven PA; van de Langenberg R; Colnot DR; Quak JJ
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1713-1722. PubMed ID: 36208330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings.
    Vercruysse JP; De Foer B; Somers T; Casselman J; Offeciers E
    J Laryngol Otol; 2010 Jan; 124(1):37-43. PubMed ID: 19775491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Bony Obliteration Tympanoplasty in Pediatric Cholesteatoma: Long-term Hearing Results.
    van Dinther JJS; Coopman R; Vercruysse JP; Somers T; Zarowski A; Vanspauwen R; Maryn Y; Cremers CWRJ; Offeciers FE
    Otol Neurotol; 2018 Jul; 39(6):715-723. PubMed ID: 29889781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatoma.
    Sun J; Sun J; Hu Y; Lv Q; Wang Y; Li X; Xu W; Wang S; Mei Z; Wan G
    Acta Otolaryngol; 2010 Feb; 130(2):259-62. PubMed ID: 19565369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obliteration of the persistently discharging mastoid cavity using the middle temporal artery flap.
    Singh V; Atlas M
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):433-8. PubMed ID: 17765771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mastoid Obliteration Using Autologous Bone Dust Following Canal Wall Down Mastoidectomy.
    Sioshansi PC; Alyono JC; Blevins NH
    Otol Neurotol; 2021 Jan; 42(1):68-75. PubMed ID: 32976343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mastoid obliteration: autogenous cranial bone pAte reconstruction.
    Roberson JB; Mason TP; Stidham KR
    Otol Neurotol; 2003 Mar; 24(2):132-40. PubMed ID: 12621322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications for and outcomes of mastoid obliteration in cochlear implantation.
    Leung R; Briggs RJ
    Otol Neurotol; 2007 Apr; 28(3):330-4. PubMed ID: 17414038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mastoid cavity obliteration with combined palva flapand bone pâté.
    Ghiasi S
    Iran J Otorhinolaryngol; 2015 Jan; 27(78):23-8. PubMed ID: 25745608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term results following mastoid obliteration in canal wall down tympanomastoidectomy].
    Beutner D; Stumpf R; Zahnert T; Hüttenbrink KB
    Laryngorhinootologie; 2007 Dec; 86(12):861-6. PubMed ID: 17724623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Obliteration in the Achievement of a Dry Mastoid Bowl.
    Harun A; Clark J; Semenov YR; Francis HW
    Otol Neurotol; 2015 Sep; 36(9):1510-7. PubMed ID: 26375974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
    Kim CW; Oh JI; Choi KY; Park SM; Park MI
    Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mastoid cavity obliteration: our experience.
    Deshmukh S; Sharma A; Dabholkar J
    Otolaryngol Pol; 2012; 66(6):379-81. PubMed ID: 23200556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analyses of the operative efficacy of 102 cases of acquired middle ear cholesteatoma].
    Yang B; Jiang X; Yang N; Hui L; Wang B; Sun Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):338-42. PubMed ID: 27220292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mid-temporal pericranial and inferiorly based periosteal flaps in mastoid obliteration.
    Yung M; Smith P
    Otolaryngol Head Neck Surg; 2007 Dec; 137(6):906-12. PubMed ID: 18036419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mastoidectomy cavity obliteration with bioactive glass: a pilot study.
    Silvola JT
    Otolaryngol Head Neck Surg; 2012 Jul; 147(1):119-26. PubMed ID: 22371341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
    Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
    Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesteatoma recidivism: comparison of three different surgical techniques.
    Neudert M; Lailach S; Lasurashvili N; Kemper M; Beleites T; Zahnert T
    Otol Neurotol; 2014 Dec; 35(10):1801-8. PubMed ID: 24914796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesteatoma surgery in children: long-term results of the inside-out technique.
    Roth TN; Ziglinas P; Haeusler R; Caversaccio MD
    Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):843-6. PubMed ID: 23566425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.